Roberto Bolli Selected Research

Roberto Bolli Research Topics

Disease

58	Myocardial Infarction 02/2022 - 08/2002
44	Infarction (Infarctions) 10/2021 - 08/2002
28	Ischemia 08/2015 - 03/2002
27	Coronary Occlusion 04/2023 - 01/2002
25	Heart Failure 01/2024 - 05/2005
21	Reperfusion Injury 01/2019 - 08/2002
16	Myocardial Ischemia (Ischemic Heart Diseases) 01/2019 - 02/2003
14	Cardiomyopathies (Cardiomyopathy) 10/2023 - 08/2013
12	Cicatrix (Scar) 10/2023 - 05/2007
10	Left Ventricular Dysfunction 01/2021 - 06/2008
8	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 04/2003
7	Fibrosis (Cirrhosis) 04/2023 - 01/2010
6	Myocardial Stunning (Stunned Myocardium) 04/2003 - 01/2002
5	Heart Diseases (Heart Disease) 05/2021 - 02/2016
5	Coronary Artery Disease (Coronary Atherosclerosis) 01/2018 - 11/2004
4	Necrosis 05/2015 - 01/2003
4	Hypertrophy 07/2014 - 05/2005
3	Hypoxia (Hypoxemia) 12/2021 - 05/2005
3	Stroke (Strokes) 04/2017 - 01/2011
2	Carcinogenesis 01/2022 - 08/2002
2	Ventricular Remodeling 11/2021 - 04/2016
2	Cardiotoxicity 11/2020 - 01/2019
2	Neoplasms (Cancer) 11/2020 - 01/2004
2	Peripheral Arterial Disease 04/2017 - 09/2013
2	ST Elevation Myocardial Infarction 01/2017 - 01/2017
2	Inflammation (Inflammations) 07/2014 - 02/2006
2	Hypercholesterolemia 10/2005 - 11/2004
1	Infections 01/2022
1	Cardiac Arrhythmias (Arrythmia) 01/2022

Drug/Important Bio-Agent (IBA)

11	Proteins (Proteins, Gene)FDA Link 08/2015 - 01/2002
10	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 03/2012 - 02/2003
7	CytokinesIBA 06/2017 - 11/2004
6	CollagenIBA 10/2023 - 10/2010
6	salicylhydroxamic acid (SHAM)IBA 10/2021 - 01/2002
6	Biomarkers (Surrogate Marker)IBA 01/2021 - 10/2014
6	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2019 - 11/2002
5	cytidylyl-(3'-5')-cytidine (CpC)IBA 08/2016 - 03/2008
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2016 - 07/2004
3	omega-Chloroacetophenone (Mace)IBA 01/2021 - 01/2018
3	EnzymesIBA 01/2019 - 05/2005
3	AldehydesIBA 01/2019 - 06/2008
3	Acrolein (Aqualin)IBA 01/2019 - 06/2008
3	Oxygen (Dioxygen)IBA 01/2019 - 09/2013
3	Insulin (Novolin)FDA Link 07/2014 - 07/2008
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 04/2013 - 07/2008
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 11/2012 - 11/2004
3	Caspase 3 (Caspase-3)IBA 01/2012 - 05/2005
3	tricarbonylchloro(glycinato)ruthenium(II)IBA 01/2012 - 05/2004
3	enhanced green fluorescent proteinIBA 06/2011 - 06/2008
3	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 10/2009 - 04/2006
3	SodiumIBA 04/2008 - 01/2003
3	cariporideIBA 04/2008 - 01/2003
3	HydrogenIBA 04/2008 - 01/2003
3	Telomerase (Telomerase Reverse Transcriptase)IBA 03/2008 - 06/2005
3	Nitric Oxide Synthase (NO Synthase)IBA 03/2008 - 04/2003
3	1- hydroxy- 2- oxo- 3,3- bis(2- aminoethyl)- 1- triazeneIBA 11/2005 - 04/2003
3	EndotoxinsIBA 05/2005 - 01/2002
3	Opioid Analgesics (Opioids)IBA 01/2004 - 08/2002
3	N- (2- cyclohexyloxy- 4- nitrophenyl)methanesulfonamideIBA 01/2004 - 11/2002
2	AnthracyclinesIBA 11/2020 - 01/2018
2	Free RadicalsIBA 01/2019 - 08/2015
2	Dimethyl Sulfoxide (DMSO)FDA LinkGeneric 11/2018 - 05/2015
2	Glucose (Dextrose)FDA LinkGeneric 06/2016 - 11/2008
2	Trypan Blue FDA Link 05/2015 - 08/2007
2	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 04/2013 - 07/2008
2	Heme Oxygenase-1IBA 09/2012 - 11/2011
2	erucylphosphocholineIBA 09/2012 - 11/2006
2	Transcription Factors (Transcription Factor)IBA 01/2012 - 07/2004
2	ProstaglandinsIBA 01/2012 - 07/2004
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2011 - 01/2006
2	plerixafor FDA Link 10/2010 - 08/2007
2	LigandsIBA 10/2009 - 04/2006
2	diethylenetriamineIBA 11/2008 - 11/2004
2	CalciumIBA 04/2008 - 01/2003
2	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 10/2007 - 10/2005
2	Celecoxib (Celebrex)FDA Link 10/2007 - 11/2002
2	Phosphotransferases (Kinase)IBA 08/2007 - 10/2003
2	Protein Kinase C-epsilonIBA 09/2005 - 03/2002
2	InterleukinsIBA 05/2005 - 10/2004
2	Saline SolutionIBA 05/2005 - 04/2004
2	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 10/2004 - 08/2002
2	Adenosine (Adenocard)FDA LinkGeneric 07/2004 - 08/2003
2	Messenger RNA (mRNA)IBA 07/2004 - 01/2002
2	NF-kappa B (NF-kB)IBA 07/2004 - 10/2003
2	BW 373U86IBA 01/2004 - 11/2002
2	Adenosine Triphosphate (ATP)IBA 12/2002 - 03/2002
1	PeriostinIBA 04/2023
1	Coloring Agents (Dyes)IBA 04/2023
1	trichrome stainIBA 04/2023
1	CDC2 Protein Kinase (Protein p34cdc2)IBA 01/2022
1	Cyclin-Dependent Kinase 4IBA 01/2022

Therapy/Procedure

29	Therapeutics 01/2024 - 04/2003
24	Cell- and Tissue-Based Therapy (Cell Therapy) 10/2023 - 08/2013
11	Transplantation 01/2020 - 11/2005
5	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 09/2012 - 01/2003
4	Injections 01/2016 - 02/2006
3	Intravenous Infusions 02/2022 - 04/2003
3	Intraventricular Infusions 03/2021 - 01/2018
2	Intravenous Administration 10/2023 - 02/2022
2	Aftercare (After-Treatment) 01/2022 - 11/2002